Indexed keywords
ANTICOAGULANT AGENT;
WARFARIN;
ANTICOAGULATION;
BLEEDING;
BRAIN HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL (TOPIC);
CONFERENCE PAPER;
DRUG FATALITY;
DRUG SUBSTITUTION;
EMBOLISM;
HEALTH CARE COST;
HEART ATRIUM FIBRILLATION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
PRIORITY JOURNAL;
THROMBOEMBOLISM;
ADMINISTRATION, ORAL;
ANTICOAGULANTS;
FEMALE;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
MALE;
MONITORING, PHYSIOLOGIC;
WARFARIN;
1
0029741822
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
DOI 10.1056/NEJM199608223350802
Hylek EM, Skates SJ, Sheehan MA, Singer DE (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335:540-546 (Pubitemid 26272308)
(1996)
New England Journal of Medicine , vol.335
, Issue.8
, pp. 540-546
Hylek, E.M.1
Skates, S.J.2
Sheehan, M.A.3
Singer, D.E.4
2
0028343127
Risk factors for intracranial hemorrhage in outpatients taking warfarin
Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897-902 (Pubitemid 24179151)
(1994)
Annals of Internal Medicine , vol.120
, Issue.11
, pp. 897-902
Hylek, E.M.1
Singer, D.E.2
3
33847006936
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: Results from SPORTIF III and v
17296878 10.1001/archinte.167.3.239 1:CAS:528:DC%2BD2sXisFyktbo%3D
White HD, Gruber M, Feyzi J et al (2007) Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 167:239-245
(2007)
Arch Intern Med , vol.167
, pp. 239-245
White, H.D.1
Gruber, M.2
Feyzi, J.3
4
70349306707
Dabigatran versus warfarin in patients with atrial fibrillation
19717844 10.1056/NEJMoa0905561 1:CAS:528:DC%2BD1MXhtFOjsLnN
Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
(2009)
N Engl J Med , vol.361
, pp. 1139-1151
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
5
80052592404
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
21830957 10.1056/NEJMoa1009638 1:CAS:528:DC%2BC3MXhtFKhsLnI
Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883-891
(2011)
N Engl J Med , vol.365
, pp. 883-891
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
6
80052825103
Apixaban versus warfarin in patients with atrial fibrillation
21870978 10.1056/NEJMoa1107039 1:CAS:528:DC%2BC3MXhtF2ms7rN
Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981-992
(2011)
N Engl J Med , vol.365
, pp. 981-992
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
7
70349254549
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
19439733 10.1182/blood-2009-02-207928 1:CAS:528:DC%2BD1MXps1eit7o%3D
Witt DM, Delate T, Clark NP et al (2009) Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 114:952-956
(2009)
Blood , vol.114
, pp. 952-956
Witt, D.M.1
Delate, T.2
Clark, N.P.3
8
77952728946
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users
20398186 10.1111/j.1538-7836.2010.03756.x 1:CAS:528:DC%2BC3cXlvVGks7k%3D
Witt DM, Delate T, Clark NP et al (2010) Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost 8:744-749
(2010)
J Thromb Haemost , vol.8
, pp. 744-749
Witt, D.M.1
Delate, T.2
Clark, N.P.3
